logo
Select company
Select metric
$ 6.05MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
25
Sector
45
Industry
56
History
23
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 6.05M
3/31/2025$ 9.4M
12/31/2024$ 12.84M
9/30/2024$ 10.32M
6/30/2024$ 10.19M
3/31/2024$ 6.86M
12/31/2023$ 3.41M
9/30/2023$ 1.59M
6/30/2023$ 1.71M
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) CF - Equity stands at $ 2.67M.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average CF - Equity has been $ 6.14M.
  • The median CF - Equity for LEXARIA BIOSCIENCE CORP during this period was $ 5.03M
  • LEXARIA BIOSCIENCE CORP reached its highest CF - Equity over the past 5 years at $ 13.49M.
  • The lowest CF - Equity recorded by LEXARIA BIOSCIENCE CORP in the same timeframe $ 0

LEXARIA BIOSCIENCE CORP's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
BRTX : BIORESTORATIVE THERAPIES INC $ 2.05MIBIO : IBIO INC $ 3.67MERNA : ERNEXA THERAPEUTICS INC $ 5.93MICU : SEASTAR MEDICAL HOLDING CORP $ 18.11MRLYB : RALLYBIO CORP $ 28KLYRA : LYRA THERAPEUTICS INC $ 5MPULM : PULMATRIX INC $ 0VYNE : VYNE THERAPEUTICS INC $ 0APRE : APREA THERAPEUTICS INC $ 573.98KMGRX : MANGOCEUTICALS INC $ 3.63M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

LEXX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Sep 30, 2022

$ 13.49M

Maximum

Sep 30, 2021

$ 6.14M

Average

$ 5.03M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M